`Date Filed: April 30, 2015
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`________________
`
`LUPIN LIMITED
`Petitioner
`
`v.
`
`JANSSEN SCIENCES IRELAND UC
`Patent Owner
`
`________________
`
`Case IPR2015-01030
`Patent 8,518,987 B2
`
`________________
`
`
`JANSSEN SCIENCES IRELAND UC’S MANDATORY NOTICES
`
`
`
`
`
`
`Janssen Sciences Ireland UC submits the following mandatory disclosures
`
`pursuant to 37 C.F.R. §42.8.
`
`REAL PARTY-IN-INTEREST
`
`Janssen Sciences Ireland UC (“Janssen”), an indirect, wholly-owned
`
`subsidiary of Johnson & Johnson (“J&J”), is a real party-in-interest. Janssen
`
`Products, L.P., a wholly-owned subsidiary of J&J is also a real party-in-interest. In
`
`addition, J&J, a publicly held company, is a real party-in-interest.
`
`
`
`RELATED MATTERS
`
`U.S. Patent 8,518,987 (the “’987 Patent”) issued from U.S. Application No.
`
`12/536,807 (the “’807 Application”). U.S. Patent Application No. 14/183,712,
`
`which is currently pending before the Office, is a continuation of U.S. Application
`
`13/939,494 (now abandoned), which is itself a continuation of the ’807
`
`Application.
`
`The ’987 Patent is being asserted in the following patent infringement
`
`lawsuits:
`
`• Janssen Prods., L.P. et al. v. Lupin Ltd. et al., C.A. No. 13-3891
`
`(D.N.J.);
`
`• Janssen Prods., L.P. et al. v. Cipla Ltd. et al., C.A. No. 14-5093
`
`(D.N.J.);
`
`2
`
`
`
`• Janssen Prods., L.P. et al. v. Cipla Ltd. et al., C.A. No. 14-1056 (D.
`
`Del.);
`
`• Janssen Prods., L.P. et al. v. Cipla Ltd. et al., C.A. No. 15-0307 (D.
`
`Del.); and
`
`• Janssen Prods., L.P. et al. v. Cipla Ltd. et al., C.A. No. 15-2549
`
`(D.N.J.).
`
`The ’987 Patent was at issue in the following lawsuits that have now been
`
`terminated:
`
`• Janssen Prods., L.P. et al. v. Teva Pharm. USA, Inc. et al., C.A. No.
`
`13-7576 (D.N.J.) (terminated due to consent judgment of
`
`enforceability, validity and infringement of the ’987 patent with
`
`respect to Teva ANDA product); and
`
`• Janssen Prods., L.P. et al. v. Lupin Ltd. et al., C.A. No. 14-1370
`
`(D.N.J.) (terminated due to consolidation with C.A. No. 13-3891).
`
`The ’807 Application is a divisional of U.S. Application No. 10/514,352,
`
`which issued as U.S. Patent No. 7,700,645 (the “’645 Patent”). The ’645 Patent is
`
`the subject of the following lawsuits:
`
`• Janssen Prods., L.P. et al. v. Lupin Ltd. et al., C.A. No. 10-5954
`
`(D.N.J.) (pending Consolidated Appeal No. 14-1842 (Fed. Cir.));
`
`3
`
`
`
`• Janssen Prods., L.P. et al. v. Lupin Ltd. et al., C.A. No. 13-3891
`
`(D.N.J.) (also listed above with respect to the ’987 Patent);
`
`• Janssen Prods., L.P. et al. v. Cipla Ltd. et al., C.A. No. 14-1056 (D.
`
`Del.) (also listed above with respect to the ’987 Patent);
`
`• Janssen Prods., L.P. et al. v. Cipla Ltd. et al.,C.A. No. 14-5093
`
`(D.N.J.) (also listed above with respect to the ’987 Patent);
`
`• Janssen Prods., L.P. et al. v. Cipla Ltd. et al., C.A. No. 15-0307 (D.
`
`Del.) (also listed above with respect to the ’987 Patent); and
`
`• Janssen Prods., L.P. et al. v. Cipla Ltd. et al., C.A. No. 15-2549
`
`(D.N.J.) (also listed above with respect to the ’987 Patent).
`
`The ’645 Patent was at issue in the following lawsuits that have now been
`
`terminated:
`
`• Tibotec Inc. et al. v. Teva Pharm. USA, Inc. et al., C.A. No. 11-1509
`
`(D.N.J.) (consolidated with C.A. No. 10-5954 and dismissed due to
`
`consent judgment of enforceability, validity and infringement of the
`
`’645 patent with respect to Teva ANDA product); and
`
`• Tibotec Inc. et al. v. Lupin Ltd. et al., C.A. No. 11-4027 (D.N.J.)
`
`(terminated due to consolidation with C.A. No. 10-5954).
`
`4
`
`
`
`
`
`LEAD AND BACKUP COUNSEL
`
`Lead Counsel
`
`Dianne B. Elderkin
`AKIN GUMP STRAUSS HAUER
`& FELD LLP
`Two Commerce Square
`2001 Market Street, Suite 4100
`Philadelphia, PA 19103
`Tel.: (215) 965-1340
`Fax: (215) 965-1210
`delderkin@akingump.com
`USPTO Registration No. 28,598
`
`
`
`
`Backup Counsel
`
`
`
`Barbara L. Mullin
`AKIN GUMP STRAUSS HAUER
`& FELD LLP
`Two Commerce Square
`2001 Market Street, Suite 4100
`Philadelphia, PA 19103
`Tel.: (215) 965-1243
`Fax: (215) 965-1210
`bmullin@akingump.com
`USPTO Registration No. 38,250
`
`Ruben H. Munoz
`AKIN GUMP STRAUSS HAUER
`& FELD LLP
`Two Commerce Square
`2001 Market Street, Suite 4100
`Philadelphia, PA 19103
`Tel.: (215) 965-1263
`Fax: (215) 965-1210
`rmunoz@akingump.com
`USPTO Registration No. 66,998
`
`Irena Royzman
`PATTERSON BELKNAP WEBB &
`TYLER LLP
`1133 Avenue of the Americas
`New York, NY 10036
`Tel.: (212) 336-2081
`Fax: (212) 336-2222
`iroyzman@pbwt.com
`USPTO Registration No. 73,354
`
`Gregory L. Diskant
`PATTERSON BELKNAP WEBB &
`TYLER LLP
`1133 Avenue of the Americas
`
`5
`
`
`
`New York, NY 10036
`Tel.: (212) 336-2710
`Fax: (212) 336-2222
`gldiskant@pbwt.com
`pro hac vice to be requested
`
`Pursuant to 37 C.F.R. § 42.10(b), a Power of Attorney was filed with the
`
`original Mandatory Notices on April 30, 2015.
`
`
`
`SERVICE INFORMATION
`
`Janssen may be served electronically using the following email addresses:
`
`JANS-LUPIN@akingump.com
`LupinIPR@pbwt.com
`
`Janssen may be served by postal mailing or hand-delivery as follows:
`
`Dianne B. Elderkin
`AKIN GUMP STRAUSS HAUER & FELD LLP
`Two Commerce Square
`2001 Market Street, Suite 4100
`Philadelphia, PA 19103
`Tel.: (215) 965-1259
`Fax: (215) 965-1210
`
`Irena Royzman
`PATTERSON BELKNAP WEBB & TYLER LLP
`1133 Avenue of the Americas
`New York, NY 10036
`Tel.: (212) 336-2081
`Fax: (212) 336-2222
`
`
`
`6
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`
`/Dianne B. Elderkin/
`Dianne B. Elderkin
`Registration No. 28,598
`Counsel for Patent Owner
`
`
`
`
`
`Date: April 30, 2015
`
`
`
`7
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing mandatory
`
`notices was caused to be served on counsel for Petitioner on April 30, 2015, by
`
`delivering a copy via Federal Express for overnight delivery as follows:
`
`Deanne M. Mazzochi
`Tara M. Raghavan
`RAKOCZY MOLINO MAZZOCHI SIWIK LLP
`6 West Hubbard Street, Suite 500
`Chicago, IL 60654
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`By: /Dianne B. Elderkin/
`Dianne B. Elderkin
`Registration No. 28,598
`Counsel for Patent Owner
`
`8
`
`Date: April 30, 2015